The Beyond Celiac Newsletter

Monthly Newsletter

Easy Pumpkin Soup

It’s that time of year! An easy Autumnal recipe for those chilly days and nights.



Snickerdoodle, Ginger or Chocolate Chip Crisps

A delicious treat to serve this holiday season. Who doesn’t love freshly baked snickerdoodle cookies?


About Chef Oonagh Williams

Celiac disease scientists discuss discoveries they are making with help from Beyond Celiac grants

Researchers update studies of killer cells, celiac disease screening and a more precise way to measure intestinal damage.

Beyond Celiac joins forces with National Minority Quality Forum

This unique partnership aims to shine a spotlight on disparity in the diagnosis of celiac disease.

New celiac disease drug candidate, KAN-101, in Phase 1 clinical trials
New potential treatment for celiac disease aims to re-educate the immune system so it does not react to gluten.

Celiac disease patients not at increased risk of getting COVID-19
A survey of more than 10,000 celiac disease patients around the world found the risk of getting COVID-19 was not increased compared to the general population.

Phase 2 study relaunching in November
Celiac disease study postponed due to COVID-19 is relaunching in November.

Clinical Trials

New Phase 2 Clinical Trial for Ongoing Celiac Symptoms

Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?

The PROACTIVE Celiac Study is looking for people between the ages of 18 and 70, who have biopsy-confirmed celiac disease and have been on a gluten-free diet for at least the last 12 months. You will not be asked to ingest gluten in this study. The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.

Learn More
See if You Qualify
Use referral code: REFBC

Beyond Celiac Chosen as Exclusive Patient Organization to Recruit for First-Ever Phase 3 Clinical Trial

Beyond Celiac has been chosen by 9 Meters Biopharma, Inc. (Nasdaq: NMTR) as the exclusive patient organization to recruit for the first-ever Phase 3-stage clinical trial therapeutic for treatment of celiac disease.

Read more

Allergic Living Spotlight

Allergy-Friendly, Bread-Free Lunch Ideas Kids Will Love

Back-to-school season means the return to packing school lunches. For families who have children with food allergies, taking time to prepare a meal is essential to keeping your kids well-fed and safe.

News, Events & Updates

WATCH: Research Grant Awardee Interview with Doctor Marisa Gallant Stahl

As the recipient of the Beyond Celiac/SSCD Young Investigator grant, she is working on the Autoimmunity for Kids (ASK) study, a free health screening program open to all Colorado children, from one to 17-years-old, designed to detect celiac disease and type 1 diabetes.

WATCH: Research Grant Awardee Interview with Doctor Jocelyn Silvester

Jocelyn Silvester, MD, director of research of the Celiac Disease Program at Boston Children’s Hospital, is the recipient of the Beyond Celiac Pilot and Feasibility grant. Silvester is investigating the use of RNA sequencing as a more exact way to measure intestinal damage revealed in a biopsy.

WATCH: Research Grant Awardee Interview with Doctor Paul Klenerman

He has received the Beyond Celiac Established Investigator Award and is studying killer cells that cause the actual tissue damage in celiac disease. Dr. Klenerman is currently also playing a key role in the search for answers about COVID-19 as part of the COVID-19 Genomics UK Consortium.

Raise Money for Beyond Celiac on Facebook!